A PROSPECTIVE OPEN-LABEL TRIAL OF EXTENDED-RELEASE LIQUID METHYLPHENIDATE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN ADULTS WITH HIGH-FUNCTIONING AUTISM SPECTRUM DISORDER: AN INTERIM ANALYSIS

Authors
Category Primary study
JournalJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Year 2017
This article has no abstract
Epistemonikos ID: fbd08676c56e678ce0967f3fad924ca6bc80db7b
First added on: Feb 08, 2025